In the complex world of rare diseases, even small advances in understanding can make a profound difference in patients’ lives. Medscape Live is bringing back-to-back educational programs to San Diego ...

Jackie is a retired nurse who began experiencing mysterious symptoms, like severe headaches, diarrhea, and itchy rashes, in the late 1990s. About a decade later, her dermatologist noticed spots on her ...

It’s a condition few have heard of; but for up to 1 in every 5,000 adults, it can be a serious challenge. Indolent systemic mastocytosis is a rare disease that can cause a wide range of unpredictable ...

Paris, July 18, 2025. Sanofi today announces the completion of its acquisition of Blueprint Medicines Corporation (Blueprint), adding to its portfolio a commercialized medicine, a promising pipeline, ...

Cogent Biosciences, Inc. (NASDAQ:COGT) is one of the best small-cap stocks to buy according to billionaires. On July 7, Jefferies increased its price target on Cogent Biosciences, Inc. (NASDAQ:COGT) ...

Blueprint Medicines Corporation (NASDAQ:BPMC) is one of the best biotech stocks to invest in now. On June 12, Blueprint Medicines announced new data reinforcing the sustained clinical efficacy and ...

Kate Haviland is CEO of Blueprint Medicines. From the Boston Business Journal. Sanofi is acquiring Blueprint Medicines Corp. and its rare immunology disease treatment, which is already approved in the ...

The Stoxx Europe 600 index was down 0.1%, France's CAC 40 was lower by 0.2%, and Germany's DAX was off by 0.3%. The U.K.'s FTSE 100 closed marginally in the black, with a 0.02% gain. President Donald ...

European stock markets ended the first trading day of the week lower. The Stoxx Europe 600 index was down 0.1%, France's CAC 40 was lower by 0.2%, and Germany's DAX was off by 0.3%. The U.K.'s FTSE ...

Sanofi SA (NASDAQ:SNY) on Monday agreed to acquire Blueprint Medicines Corporation (NASDAQ:BPMC). The acquisition includes a rare immunology disease medicine, Ayvakit/Ayvakyt (avapritinib), approved ...